Experimental acute gastrointestinal disease caused by the pyrrolizidine alkaloid, lasiocarpine.
D000018:Abomasum / Q000473:pathology; D000818:Animals; D003106:Colon / Q000473:pathology; D003108:Colonic Diseases / Q000662:veterinary; D004378:Duodenal Diseases / Q000662:veterinary; D004386:Duodenum / Q000473:pathology; D005767:Gastrointestinal Diseases / Q000662:veterinary*; D007082:Ileum / Q000473:pathology; D007410:Intestinal Diseases / Q000662:veterinary; D007583:Jejunum / Q000473:pathology; D008297:Male; D051379:Mice; D011763:Pyrrolizidine Alkaloids / Q000008:administration & dosage / Q000633:toxicity*; D051381:Rats; D012376:Rodent Diseases / Q000139:chemically induced* / Q000473:pathology; D012756:Sheep; D012757:Sheep Diseases / Q000139:chemically induced* / Q000473:pathology; D013270:Stomach / Q000473:pathology; D013272:Stomach Diseases / Q000662:veterinary
D011763:Pyrrolizidine Alkaloids